Medicalsystem Biotechnology (300439.SZ) subsidiary has obtained multiple medical device registration certificates.
Meikang Biology (300439.SZ) announced that its holding subsidiary, Jiangxi Meikang Shengde Bio-Technology Co., Ltd. (...
Medicalsystem Biotechnology(300439.SZ) announced that its holding subsidiary, Jiangxi Meikangshengde Biotechnology Co., Ltd. (referred to as "Jiangxi Meikang"), has obtained the Medical Device Registration Certificate (In Vitro Diagnostic Reagent) issued by the Jiangxi Province Drug Administration. The products include: Tissue Type Plasminogen Activator-Inhibitor 1 Complex Test Kit (Chemiluminescent Immunoassay), Thrombin-Antithrombin Complex Test Kit (Chemiluminescent Immunoassay), Thrombin Regulation Protein Test Kit (Chemiluminescent Immunoassay), and Plasmin-2 Plasmin Inhibitor Complex Test Kit (Chemiluminescent Immunoassay).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


